Tal Caller
@CallerTal
Followers
42
Following
59
Media
0
Statuses
32
MD Ph.D student at Tel Aviv University
Joined August 2021
Extremely important fundamental translational work. Nicely demostrating how cardiovascular disease is associated with cancer progression. The association goes far beyond shared risk factors ! Congratulations @CallerTal and team. @TAUMedFaculty @CardioOncology @sheba_medical
So proud of @CallerTal for winning the #ESC2025 (European Society of Cardiology) Young Investigator Award for Basic and Translational Sciences!!! 🇮🇱🏆👏🏼👏🏼👏🏼 To read more about our winning abstract: https://t.co/J37IdExJg8
#ESC2025 @escardio @TAUMedFaculty @ShebaResearch
0
2
10
So proud of @CallerTal for winning the #ESC2025 (European Society of Cardiology) Young Investigator Award for Basic and Translational Sciences!!! 🇮🇱🏆👏🏼👏🏼👏🏼 To read more about our winning abstract: https://t.co/J37IdExJg8
#ESC2025 @escardio @TAUMedFaculty @ShebaResearch
1
4
21
Huge congratulations to all of the #ESCCongress Young Investigator Award winners and runners up! A fantastic achievement ❤️🌍 @escardio #CardioTwitter #CardioX #CVD #CardiovascularResearch
1
10
33
Congrats to @Itelman_Edi for presenting in the Young Investigator Awards session on valvular heart disease, and to @CallerTal for winning in basic & translational science! Well deserved 👏🏻🏅
1
2
13
Next #Young #Investigator session on #basicscience with subjects ranging from #HFpEF to #GeneTherapy and #CellInteractions it's going to be a good one! #ESCCongress
@AnaMGmez4 @CarolRemme @liberale_luca @KralerSimon @sarandanimani @SluimerJudith @Tal_Caller @shinakito
0
6
13
Read our @Nature Cardiovascular Health review on AI-assisted cardiac #POCUS! Revolutionizing preventive cardiology by detecting biological CV age, valvular disease, AF, heart failure & more. @TelAvivUni @IdoCohe11037928 #AIinMedicine #cardiotwitter
https://t.co/d76FI1ItmO
2
4
17
@CircRes Compendium on Interorgan Crosstalk in #HeartFailure and #Cardiometabolic Diseases Insights into Heart-#Tumor Interactions in Heart Failure https://t.co/sJEoaeC7PG Authored by @CallerTal & colleagues. @LEORJONATHAN @KathrynMooreLab @SeanM_Wu @LorenzLehmann
0
5
17
Excited to share our new review on heart–tumor interactions in heart failure, now out in Circulation Research! Huge thanks to Jonathan Leor and our team. https://t.co/FUsWEkfwpm
@CircRes @leorj55
ahajournals.org
Heart failure (HF) often coexists with cancer. Beyond the known cardiotoxicity of some cancer treatments, HF itself has been associated with increased cancer incidence. The 2 conditions share common...
0
0
1
Insights Into Heart-Tumor Interactions in Heart Failure | Circulation Research https://t.co/htAspSchTN Our review paper (@CallerTal 1st author) published in @CircRes, discussing pathways and mechanisms connecting heart disease to certain cancers. @TelAvivUni
ahajournals.org
Heart failure (HF) often coexists with cancer. Beyond the known cardiotoxicity of some cancer treatments, HF itself has been associated with increased cancer incidence. The 2 conditions share common...
0
1
2
The year in cardiovascular medicine 2024: the top 10 papers in cardio-oncology. Read more in #EHJ
@escardio @ESC_Journals #CardioTwitter #CardioOncology
https://t.co/YmnfvnEMXl
0
14
41
The interplay between #CVD & cancer is bidirectional & #ASCVD resulted in being associated with a significantly increased risk of #cancer, specifically at a metastatic stage. https://t.co/vn3ymln9fu
#JACCCardioOnc #CardioOnc @LEORJONATHAN @maor_elad @CallerTal @NiliShani
1
5
19
Our work featured in a @JACCJournals editorial by Pietro Ameri (@UniGenova) & @sdent_cardioonc! Super talented @callerTal dives into the interplay of CVD & metastatic cancer (reverse cardio-oncology). The ediorial is insightful, concise and open access: https://t.co/81Q7QCvNwZ
0
4
14
#ASCVD is assoc w/ sig increased risk of cancer, specifically #metastasis at the time of cancer Dx, particularly in middle-aged adults. Recognizing this assoc could enhance the prevention & Tx of metastatic cancer in pts w/ ASCVD https://t.co/5F0otyjLKy
#JACCCardioOnc #CardioOnc
0
9
18
Our new findings from the largest national preventive healthcare screening program and cancer registry reveal that ASCVD is linked to a higher risk of metastasis at cancer diagnosis, especially in middle-aged adults. Read: https://t.co/bOEYSWedOo
@JACCJournals @CallerTal
0
3
18
#OriginalResearch: Cardiac small extracellular vesicles carry multiple pro-tumorigenic factors and can accelerate tumor growth.Treatment with spironolactone reduces accelerated tumor growth after MI.
0
4
5
Cardiovascular disorders promote solid tumor growth!!! 🫀☠️ Awesome & 🤯 study pioneered by @LEORJONATHAN & @CallerTal. Stay tuned as we further dwell into connecting CVD and development of hematological malignancies! https://t.co/BLhJ5jhZi1
0
2
7
#newresearch @TAUMedFaculty, finds a mechanism that explains why #heartdisease increases the incidence #Cancer. Full findings @CircAHA: https://t.co/GbuOFUUQSB
@TelAvivUni @Tel_Aviv_Uni @LEORJONATHAN @CallerTal @NiliShani
1
5
8
#OriginalResearch: Cardiac small extracellular vesicles carry multiple pro-tumorigenic factors and can accelerate tumor growth.Treatment with spironolactone reduces accelerated tumor growth after MI.
ahajournals.org
BACKGROUND: Myocardial infarction (MI) and heart failure are associated with an increased incidence of cancer. However, the mechanism is complex and unclear. Here, we aimed to test our hypothesis...
0
10
13
Exciting news! Our latest research, published ahead of print in @CircAHA, uncovers a unique pathway connecting heart disease to certain cancers. Led by @CallerTal and a dedicated team, this work marks a crucial step forward. @TelAvivUni @SHEBA #ExtracellularVesicles
1
6
30